Cite
Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.
MLA
Redmond, William L., et al. “Combined Targeting of Costimulatory (OX40) and Coinhibitory (CTLA-4) Pathways Elicits Potent Effector T Cells Capable of Driving Robust Antitumor Immunity.” Cancer Immunology Research, vol. 2, no. 2, Feb. 2014, pp. 142–53. EBSCOhost, https://doi.org/10.1158/2326-6066.CIR-13-0031-T.
APA
Redmond, W. L., Linch, S. N., & Kasiewicz, M. J. (2014). Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity. Cancer Immunology Research, 2(2), 142–153. https://doi.org/10.1158/2326-6066.CIR-13-0031-T
Chicago
Redmond, William L, Stefanie N Linch, and Melissa J Kasiewicz. 2014. “Combined Targeting of Costimulatory (OX40) and Coinhibitory (CTLA-4) Pathways Elicits Potent Effector T Cells Capable of Driving Robust Antitumor Immunity.” Cancer Immunology Research 2 (2): 142–53. doi:10.1158/2326-6066.CIR-13-0031-T.